Purchase Order 75D30123P17881
Award Date
9/1/23
Potential Completion Date
8/31/25
Potential Value
$237K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for MiSeq and MiniSeq sequencing systems and reagents, with a ceiling value of $132,300.66 and a period of performance through August 31, 2016. This contract does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to federal...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract is for the maintenance, repair, and support of Illumina's NovaSeq 6000 and MiSeq sequencing instruments over a 2-year period, with a ceiling value of $139,336.76. This contract does not have a set-aside designation. Illumina has previously received prime federal contracts and...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such...
This firm fixed-price federal contract award to Illumina, Inc. is for the provision of laboratory equipment, valued at $205,800.00. The contract was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh and has a ceiling value of $205,800.00. The contract does not have a set-aside designation. Based on Illumina's background as a manufacturer and provider of sequencing and genomic analysis solutions, the equipment being provided likely includes various NextSeq, NovaSeq, MiSeq,...